Total Payments
$1.7M
2024 Payments
$369,392
Companies
24
Transactions
1,226
Medicare Patients
16
Medicare Billing
$1,506
Payment Breakdown by Category
Other$1.3M (78.4%)
Consulting$193,820 (11.6%)
Travel$136,704 (8.2%)
Food & Beverage$21,057 (1.3%)
Research$7,700 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.3M | 393 | 75.4% |
| Consulting Fee | $193,820 | 76 | 11.6% |
| Travel and Lodging | $136,704 | 259 | 8.2% |
| Honoraria | $50,725 | 12 | 3.0% |
| Food and Beverage | $21,057 | 476 | 1.3% |
| Unspecified | $7,700 | 10 | 0.5% |
Payments by Type
General
$1.7M
1,216 transactions
Research
$7,700
10 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $502,679 | 271 | $0 (2024) |
| GENZYME CORPORATION | $361,900 | 254 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $326,993 | 275 | $0 (2024) |
| Lilly USA, LLC | $240,139 | 208 | $0 (2024) |
| Eli Lilly and Company | $69,232 | 34 | $0 (2024) |
| ABBVIE INC. | $61,135 | 69 | $0 (2024) |
| Incyte Corporation | $54,468 | 54 | $0 (2024) |
| Dermavant Sciences, Inc. | $26,373 | 20 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $6,833 | 4 | $0 (2024) |
| Aclaris Therapeutics, Inc. | $5,554 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $369,392 | 242 | PFIZER INC. ($126,345) |
| 2023 | $353,532 | 234 | PFIZER INC. ($145,364) |
| 2022 | $339,186 | 258 | GENZYME CORPORATION ($99,795) |
| 2021 | $187,639 | 139 | GENZYME CORPORATION ($66,427) |
| 2020 | $120,184 | 93 | Regeneron Healthcare Solutions, Inc. ($44,918) |
| 2019 | $241,519 | 198 | Regeneron Healthcare Solutions, Inc. ($109,012) |
| 2018 | $47,276 | 53 | PFIZER INC. ($47,132) |
| 2017 | $5,223 | 9 | PFIZER INC. ($5,209) |
All Payment Transactions
1,226 individual payment records from CMS Open Payments — Page 3 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $14.05 | General |
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,843.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,843.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,843.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $720.38 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $489.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/18/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $439.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $354.16 | General |
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,843.00 | General |
| Category: Immunology | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $112.92 | General |
| Category: Immunology | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,675.00 | General |
| Category: Immunology | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $1,167.74 | General |
| Category: Immunology | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $282.02 | General |
| Category: Immunology | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $126.81 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $388.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Immunology | ||||||
| 10/10/2024 | PFIZER INC. | LITFULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Inflammation & Immunology | ||||||
| 10/09/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $5.23 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RITLECITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $5,980 | 8 |
| LITFULO CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $940.00 | 1 |
| JAK 3TEC CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $780.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 16 | 26 | $4,264 | $1,506 |
Total Patients
16
Total Services
26
Medicare Billing
$1,506
Procedure Codes
1
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 26 | $4,264 | $1,506 | 35.3% |
About Dr. Brittany Craiglow, MD
Dr. Brittany Craiglow, MD is a Pediatric Dermatology healthcare provider based in Fairfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2009. The National Provider Identifier (NPI) number assigned to this provider is 1053554667.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brittany Craiglow, MD has received a total of $1.7M in payments from pharmaceutical and medical device companies, with $369,392 received in 2024. These payments were reported across 1,226 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.3M).
As a Medicare-enrolled provider, Craiglow has provided services to 16 Medicare beneficiaries, totaling 26 services with total Medicare billing of $1,506. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatric Dermatology
- Other Specialties Dermatology
- Location Fairfield, CT
- Active Since 04/13/2009
- Last Updated 04/17/2018
- Taxonomy Code 207NP0225X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053554667
Products in Payments
- DUPIXENT (Biological) $593,173
- LITFULO (Drug) $166,942
- OLUMIANT (Drug) $136,049
- CIBINQO (Drug) $98,580
- DUPIXENT (Drug) $81,799
- EUCRISA (Drug) $72,884
- RINVOQ (Biological) $59,470
- Olumiant (Drug) $54,000
- OPZELURA (Drug) $50,443
- TALTZ (Drug) $35,962
- TAPINAROF (Drug) $26,342
- Zoryve (Drug) $6,833
- EBGLYSS (Drug) $196.45
- ADBRY (Biological) $168.94
- Humira (Biological) $64.90
- VTAMA (Drug) $30.86
- Sotyktu (Drug) $26.38
- YCANTH (Drug) $23.92
- Absorica LD (Drug) $19.74
- DUOBRII (Drug) $19.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.